CECCHETTI, Violetta
 Distribuzione geografica
Continente #
NA - Nord America 6.755
EU - Europa 5.262
AS - Asia 4.560
SA - Sud America 605
AF - Africa 77
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.281
Nazione #
US - Stati Uniti d'America 6.644
SG - Singapore 1.854
IT - Italia 1.008
UA - Ucraina 892
IE - Irlanda 869
CN - Cina 775
HK - Hong Kong 686
SE - Svezia 659
VN - Vietnam 655
RU - Federazione Russa 546
BR - Brasile 524
DE - Germania 351
FI - Finlandia 263
KR - Corea 196
GB - Regno Unito 171
BE - Belgio 112
TR - Turchia 78
JP - Giappone 73
FR - Francia 69
PL - Polonia 69
IN - India 55
CA - Canada 52
MX - Messico 45
RO - Romania 44
NL - Olanda 41
CH - Svizzera 37
AR - Argentina 34
UZ - Uzbekistan 31
ZA - Sudafrica 30
BD - Bangladesh 29
AT - Austria 27
ES - Italia 27
CZ - Repubblica Ceca 26
ID - Indonesia 18
IQ - Iraq 18
EC - Ecuador 13
PK - Pakistan 13
CI - Costa d'Avorio 11
LB - Libano 11
AU - Australia 10
EG - Egitto 10
LT - Lituania 10
MA - Marocco 10
AE - Emirati Arabi Uniti 7
CL - Cile 7
DK - Danimarca 7
EU - Europa 7
GR - Grecia 7
IL - Israele 7
IR - Iran 7
BG - Bulgaria 6
SA - Arabia Saudita 6
CO - Colombia 5
KE - Kenya 5
MY - Malesia 5
UY - Uruguay 5
KZ - Kazakistan 4
PA - Panama 4
PE - Perù 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TM - Turkmenistan 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CM - Camerun 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
Totale 17.271
Città #
Singapore 1.243
Chandler 1.091
Dublin 869
Hong Kong 673
Dong Ket 487
Jacksonville 480
Perugia 463
San Mateo 460
Ashburn 373
Boardman 307
Santa Clara 257
Medford 205
Princeton 203
Seoul 193
Beijing 183
Ann Arbor 167
Wilmington 159
Altamura 146
Andover 128
Lawrence 123
Moscow 118
Los Angeles 114
Brussels 112
Munich 99
New York 91
Piscataway 76
Fremont 75
Ho Chi Minh City 72
Tokyo 66
Des Moines 65
The Dalles 62
Saint Petersburg 57
Turku 54
São Paulo 49
West Jordan 48
Warsaw 46
Izmir 44
Nanjing 43
Redmond 43
Norwalk 39
Brooklyn 36
Dearborn 36
Woodbridge 35
Dallas 34
Hanoi 31
Atlanta 29
Denver 29
Helsinki 28
Rome 28
Falls Church 27
Orem 27
Bucharest 25
Chicago 25
Spoleto 25
Columbus 24
Hefei 24
Poplar 24
San Giustino 23
Montreal 22
San Paolo di Civitate 22
Houston 21
Redwood City 21
Stockholm 21
Shanghai 19
Chennai 18
London 18
Seattle 18
Phoenix 17
San Diego 17
San Francisco 17
Ankara 16
Den Haag 16
Johannesburg 16
Philadelphia 15
Rio de Janeiro 15
Auburn Hills 14
Boston 14
Charlotte 14
Chongqing 14
San Jose 14
Secaucus 14
Hanover 13
Manchester 13
Mexico City 13
Olomouc 13
Council Bluffs 12
Curitiba 12
Guangzhou 12
Abidjan 11
Bologna 11
Porto Alegre 11
Tashkent 11
Timisoara 11
Recife 10
Amsterdam 9
Belo Horizonte 9
Brasília 9
Dhaka 9
Lappeenranta 9
Milan 9
Totale 10.693
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 308
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 302
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 290
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 289
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 231
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 173
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 154
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 153
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 145
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 137
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 137
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 129
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 125
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 125
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 124
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 122
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 118
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 116
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 114
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 113
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 112
New Insights on KCa3.1 Channel Modulation 112
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 110
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 110
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 109
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 108
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 108
6-Aminoquinolones as New Potential Anti-HIV Agents 107
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 107
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 106
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 106
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 106
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 106
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 105
6-Desfluoroquinolones as promising HIV transcription inhibitors 105
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 105
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 104
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 104
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 103
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 102
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 100
A New Derivative with Ultra-Potent Anti-HIV Activity 99
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 99
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 99
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 99
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 98
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 98
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 98
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 97
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 96
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 96
A new 6-aminoquinolone compound with anti-HCMV activity 95
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 95
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 95
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 95
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 94
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 94
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 94
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 94
The antibacterial activity of quinolones against E.coli: a chemometric study 93
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 93
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 93
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 92
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 91
QSAR study and VolSurf characterization of anti-HIV quinolone library 91
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 91
S. aureus NorA efflux pump: the discovery of new potent inhibitors 91
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 91
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 90
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 90
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 89
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 88
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 88
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 88
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 88
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 88
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 87
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 87
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 87
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 86
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 86
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 86
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 86
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 85
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 85
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 84
In Vitro Activities of New Quinolones Against Helicobacter pylori 83
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 83
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 83
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 83
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 83
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 83
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 83
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 83
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 83
One-Pot Synthesis of Rufloxacin 82
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 82
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 82
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 82
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 81
Totale 10.925
Categoria #
all - tutte 78.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.346 0 0 0 0 0 152 209 14 233 68 147 523
2021/20222.004 58 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.419 51 287 122 298 403 167 289 194 591 199 545 273
2025/20263.524 497 452 341 884 923 427 0 0 0 0 0 0
Totale 17.871